Key developments in MS: RIS, the MS prodrome, & novel MRI biomarkers

Key developments in MS: RIS, the MS prodrome, & novel MRI biomarkersПодробнее

Investigating the MS prodrome and RIS to advance understanding in MSПодробнее

Developments in utilizing MRI biomarkers in MSПодробнее

The development of clinically useful biomarkers in MSПодробнее

Genetic biomarkers of MS susceptibility and the gut microbiomeПодробнее

Imaging biomarkers of RISПодробнее

New BIOMARKER in MS?Подробнее

The central vein sign: a novel imaging biomarker for MS diagnosisПодробнее

Clinical and Radiologic Features of an MS ProdromeПодробнее

Upcoming MRI biomarkers in multiple sclerosisПодробнее

Novel biomarkers to predict progression in MSПодробнее

Pascal Sati, PhD: Validating the Central Vein Sign in Multiple Sclerosis DiagnosisПодробнее

Developing biomarkers for individual prognostication in MSПодробнее

Central vein sign to aid in MS diagnosticsПодробнее

The importance of the MS prodrome in early diagnosisПодробнее

Understanding more about MS relapse, MRI's and Biomarkers for Multiple SclerosisПодробнее

Brain MRI biomarkers in Multiple SclerosisПодробнее

Developing novel biomarkers in MS: diagnostic, predictive, & prognosticПодробнее

Controversies in MS: prodrome, DMTs & biomarkersПодробнее

Decoding the prodromal phase of MSПодробнее